Updates on the risk factors for latent tuberculosis reactivation and their managements

JW Ai, QL Ruan, QH Liu, WH Zhang - Emerging microbes & …, 2016 - Taylor & Francis
The preventive treatment of latent tuberculosis infection (LTBI) is of great importance for the
elimination and control of tuberculosis (TB) worldwide, but existing screening methods for …

Treatment of latent tuberculosis infection: an updated network meta-analysis

D Zenner, N Beer, RJ Harris, MC Lipman… - Annals of internal …, 2017 - acpjournals.org
Background: Treatment of latent tuberculosis infection (LTBI) is an important component of
tuberculosis (TB) control, and this study updates a previous network meta-analysis of the …

[HTML][HTML] Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020

TR Sterling - MMWR. Recommendations and Reports, 2020 - cdc.gov
Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among
persons living in the United States were last published in 2000 (American Thoracic Society …

Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …

P Nahid, SE Dorman, N Alipanah… - Clinical infectious …, 2016 - academic.oup.com
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis

S Swindells, R Ramchandani, A Gupta… - … England Journal of …, 2019 - Mass Medical Soc
Background Tuberculosis is the leading killer of patients with human immunodeficiency virus
(HIV) infection. Preventive therapy is effective, but current regimens are limited by poor …

Three months of rifapentine and isoniazid for latent tuberculosis infection

TR Sterling, ME Villarino, AS Borisov… - … England Journal of …, 2011 - Mass Medical Soc
Background Treatment of latent Mycobacterium tuberculosis infection is an essential
component of tuberculosis control and elimination. The current standard regimen of …

An official ATS statement: hepatotoxicity of antituberculosis therapy

JJ Saukkonen, DL Cohn, RM Jasmer… - American journal of …, 2006 - atsjournals.org
Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-
standing concern in the treatment of tuberculosis (TB) infection. The liver has a central role …

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

D Yee, C Valiquette, M Pelletier, I Parisien… - American journal of …, 2003 - atsjournals.org
Major adverse reactions to antituberculosis drugs can cause significant morbidity, and
compromise treatment regimens for tuberculosis (TB). Among patients treated for active TB …

Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa

J Hakim, V Musiime, AJ Szubert… - … England Journal of …, 2017 - Mass Medical Soc
Background In sub-Saharan Africa, among patients with advanced human
immunodeficiency virus (HIV) infection, the rate of death from infection (including …

Treatment of latent tuberculosis infection in HIV infected persons

C Akolo, I Adetifa, S Shepperd… - Cochrane database of …, 2010 - cochranelibrary.com
Background Individuals with human immunodeficiency virus (HIV) infection are at an
increased risk of developing active tuberculosis (TB). It is known that treatment of latent TB …